Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohortMohd H. Abdul‐Aziz, Jason A. Roberts, Despoina Koulenti et al.|Journal of Antimicrobial Chemotherapy|2015Cited by 164
Prolonged vs Intermittent Infusions of β-Lactam Antibiotics in Adults With Sepsis or Septic ShockMohd H. Abdul‐Aziz, Jason A. Roberts, Naomi Hammond et al.|JAMA|2024Cited by 154
Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With SepsisJoel M. Dulhunty, Megan Ratcliffe, Stephen J. Brett et al.|JAMA|2024Cited by 139
A protocol for a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsis: BLING IIIJeffrey Lipman, Joel M. Dulhunty, Stephen J. Brett et al.|Critical Care and Resuscitation|2019Cited by 46